reviewTop 1% cited
Nonpeptide angiotensin II receptor antagonists
Trends in Pharmacological Sciences · 1991 · Vol. 12(2) · pp. 55–62
Pieter B.M.W.M. Timmermans✉Pancras C. Wong(Merck & Co., Inc., Rahway, NJ, USA (United States))Andrew T. Chiu(Merck & Co., Inc., Rahway, NJ, USA (United States))William F. Herblin(Merck & Co., Inc., Rahway, NJ, USA (United States))
SAS software applications and methodsPharmacology and Obesity TreatmentAngiotensin IIAngiotensin receptorReceptorPharmacologyMedicineInternal medicine
MeSH terms
AnimalsBinding SitesHumansImidazolesRenin-Angiotensin SystemStructure-Activity RelationshipTetrazolesLosartanAngiotensin Receptor Antagonists
Citations
551
FWCI
89.53
field-weighted impact
References
26
Percentile
100%
vs. same field & year
Citations per year
Cited by
Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype.
Circulation Research · 1993 · 1,417 citations
References
Identification of angiotensin II receptor subtypes
Biochemical and Biophysical Research Communications · 1989 · 822 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.